Skip to main content
. 2004 Dec;42(12):5715–5721. doi: 10.1128/JCM.42.12.5715-5721.2004

TABLE 2.

Primers used for amplification

Target(s)a Primer Sequenceb Product size (bp) Annealing temp (°C) Nucleotide positions (bp)c GenBank accession no.d
CTX-M group I CTXM1-F3 GAC GAT GTC ACT GGC TGA GC 499 55 416-435 X92506
CTXM1-R2 AGC CG C CGA CGC TAA TAC A 914-896
CTX-M group II TOHO1-2F GCG ACC TGG TTA ACT ACA ATC C 351 55 313-334 X92507
TOHO1-1R CGG TAG TAT TGC CCT TAA GCC 663-643
CTX-M group III CTXM825F CGC TTT GCC ATG TGC AGC ACC 307 55 475-495 AF189721
CTXM825R GCT CAG TAC GAT CGA GCC 781-764
CTX-M group IV CTXM914F GCT GGA GAA AAG CAG CGG AG 474 62 1857-1876 AF252622
CTXM914R GTA AGC TGA CGC AAC GTC TG 2330-2311
a

Group I includes CTX-M-1, -3, -10 to -12, -15 (UOE-1), -22, -23, -28, -29, and -30. Group II includes CTX-M-2, -4 to -7, and -20 and Toho-1. Group III includes CTX-M-8. Group IV includes CTX-M-9, -13, -14, -16 to -19 and -21, and -27 and Toho-2. Finally, group V includes CTX-M-25 and -26.

b

Sequence of primer as synthesized 5′ to 3′.

c

Nucleotide position in base pairs for the GenBank accession number sequence.

d

Accession number of the sequence used for primer design.